Covered recipient · General Payments record
ZOZAN A AL SAADI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$423.02
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $238.82 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ANI Pharmaceuticals, Inc. | $63.38 | 2 |
| Regeneron Healthcare Solutions, Inc. | $51.73 | 2 |
| Amgen Inc. | $32.23 | 1 |
| Merck Sharp & Dohme Corporation | $32.12 | 1 |
| Inari Medical, Inc. | $26.04 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.20 | 1 |
| Esperion Therapeutics, Inc. | $13.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $32.23 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115414490 | CMS |
| ANI Pharmaceuticals, Inc. | $30.38 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091165628 | CMS |
| ANI Pharmaceuticals, Inc. | $33.00 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091138936 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.20 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117935929 | CMS |
| Esperion Therapeutics, Inc. | $13.12 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129425530 | CMS |
| Inari Medical, Inc. | $26.04 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140056424 | CMS |
| Merck Sharp & Dohme LLC | $32.12 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141743353 | CMS |
| Regeneron Healthcare Solutions, Inc. | $25.11 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113996348 | CMS |
| Regeneron Healthcare Solutions, Inc. | $26.62 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113996350 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.